Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum]

OncoTargets and Therapy, May 2017

Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum] Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum]Ye T, Su J, Huang C, et al. OncoTargets Ther. 2016;9:7481–7492.The authors have advised that a number of errors were made in some of the figures within their paper.Read the original article

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://www.dovepress.com/getfile.php?fileID=36756

Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum]

Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum] vepo lyno PowerdbyTCPDF(ww.tcpdf.org) The authors have advised that a number of errors were made in some of the figures within their paper. Page 7485, Figure 2A, the corrected image for PANC-1 protein AMPK is: On page 7486, Figure 3 was incorrect. The correct figure is: © 2017 Ye et al. This work is published and licensed by Dove Medical Press Limited. The ful terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). - .d se w u ww lan / /: o tsp rse th rp open access to scientific and medical research C O r r i g e n d u m http://dx.doi.org/10.2147/OTT.S140829 OncoTargets and Therapy 2017:10 2779–2780 (Continued) .vdoep lsyeon w u ww lan / /: o tsp rse th rp om oF fr d e d a o l n w o d y p a r e h T d n a s t e g r a T o c n O Page 7487, Figure 4B, the corrected image for PATU-8988 protein MMP2 is: for shRNA-PATU-8988 is: MMP2 – + Page 7488, Figure 4D, the corrected image for shRNAPANC-1 protein N-cadherin is: Page 7489, Figure 5A, Migration section, the corrected image for PATU-8988 at the concentration of Isoorientin160 µM is: Publish your work in this journal OncoTargets and Therapy is an international, peer-reviewed, open access journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. The journal also focuses on the impact of management programs and new therapeutic agents and protocols on Page 7490 , Figure 5B , Migration section, the corrected image


This is a preview of a remote PDF: https://www.dovepress.com/getfile.php?fileID=36756

Tingting Ye, Jiadong Su, Chaohao Huang, Dinglai Yu, Shengjie Dai, Xince Huang, Bicheng Chen, Mengtao Zhou. Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum], OncoTargets and Therapy, 2017, 2779-2780, DOI: 10.2147/OTT.S140829